Re: Richard J. Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, J. Alfred Witjes, Christian Bouffioux, Louis Denis and Donald W.W. Newling. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials. Eur Urol 2006;49:466-77

European Urology

Volumn 50, Issue 3, 2006, Pages 623-624

  Maffezzini, Massimo ^a  

^a GALLIERA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER RISK; CANCER THERAPY; CHILD HEALTH CARE; CYSTOSCOPY; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; LETTER; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THEORETICAL STUDY; TRANSURETHRAL RESECTION; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

CARCINOMA; CLINICAL TRIALS, PHASE III; CLINICAL TRIALS, PHASE III AS TOPIC; DISEASE PROGRESSION; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 33746886302     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.04.005     Document Type: Letter

References (2)

1. Wright J., Bourma S., Simunovic M.R., Levine M.N., and Whelan T.J. The importance of reporting patient recruitment details in phase III trials. J Clin Oncol 24 (2006) 843-845
2. Epstein J.L., Amin M.B., Reuter V.R., et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22 (1998) 1435-1448